ADHD treatment is not only about feeling more focused. Sometimes it is about real-world risk.
One area where this shows up clearly is driving. Adults with ADHD can struggle with sustained attention, impulsivity, distractibility, reaction time, and emotional regulation. Those symptoms do not only affect productivity. They affect a task that most adults perform every day, at speed, surrounded by other people.
Driving is also one of the few areas of ADHD impairment that has been studied with unusually good methods. That makes it a useful window into how ADHD treatment should be evaluated more generally.
What the Largest Study Found
A 2017 study in JAMA Psychiatry examined motor vehicle crash risk in more than 2.3 million people with ADHD in the United States.1 Researchers compared crash rates during months when patients were taking ADHD medication against months when the same patients were not.
The within-person design matters. Comparing medicated people to unmedicated people tells you very little, because the two groups differ in ways that are hard to measure: severity, insight, income, access to care. Comparing a person to themselves removes most of that.
Crash risk was estimated to be about 38 percent lower in males and 42 percent lower in females during medicated months compared with their own unmedicated months. The authors estimated that up to 22.1 percent of crashes involving patients with ADHD might have been avoided had they been medicated during those months.
A Study That Complicates the Picture
A second study is worth knowing about, partly because it points the other way.
In 2018, researchers published a prospective cohort study in the Journal of Psychiatric Research that took a different approach entirely.2 Rather than using insurance claims, they instrumented the vehicles of 3,226 drivers across six United States sites with data acquisition equipment and monitored actual driving continuously, engine on to engine off, for one to two years. The average driver was tracked for 440 consecutive days and roughly 9,500 miles. Crashes and near-crashes were identified by software and confirmed by coders who did not know each driver's clinical status.
Drivers reporting clinically significant ADHD symptoms had an elevated crash rate, and risk roughly doubled at the highest symptom severity. Depression carried a similar elevation, which suggests part of the effect runs through inattention rather than being unique to ADHD.
Then the finding that does not fit the tidy narrative: crash risk in that sample was not reduced by whatever ADHD treatment those drivers happened to be receiving.
How To Hold Both Findings
These two studies are not really in contradiction, and the difference between them is instructive.
The 2017 study asked whether crash risk changes when a given person moves on and off medication. The 2018 study asked whether people who are broadly "in treatment" crash less than people who are not. Those are different questions, and the second one is a much weaker test, because "usual treatment" in the community covers an enormous range: the right medication at the right dose taken consistently, and a prescription filled once in March that never got adjusted.
The honest reading is that medication taken in the months it is actually taken appears to lower crash risk substantially, and that being nominally under someone's care does not. Treatment quality is doing the work, not the label.
That is also why a medication that stopped working months ago and never got revisited is not a neutral situation. It is functionally an untreated month.
What This Does and Does Not Mean
None of this means medication eliminates driving risk. It does not. Both studies still found elevated risk in people with ADHD overall.
It also does not mean medication is the right choice for every person. Some people cannot take stimulants for medical reasons, some have a substance use history they do not want to test, and some simply do not want to. Those are legitimate positions, and there are non-stimulant options with their own evidence base.
Both studies are observational. Neither can establish that medication alone caused the reduction in crashes. Within-person designs control for a great deal, but not for everything: a month when someone is taking their medication reliably may also be a month when the rest of their life is more stable.
What the research does support is narrower and still useful. ADHD carries measurable risk in a domain that has nothing to do with paperwork, and that risk appears to move when treatment is actually working.
Why This Matters Beyond Driving
Driving is a concrete example because it is measurable. Crashes get recorded. Most ADHD impairment does not.
The same logic applies to the things that do not generate a claims record: missed medication doses for a chronic condition, financial decisions made impulsively, a job lost to a pattern nobody documented, a relationship worn down over years. ADHD affects functioning across domains, and functioning includes safety.
This is why framing ADHD treatment around productivity undersells it. Productivity is the most visible outcome, not the most important one.
Better Questions for ADHD Care
That is why good ADHD care asks more than whether symptoms are present. The more useful questions are: where is ADHD creating impairment in this person's life, what risks are specifically relevant to them, what treatment options have evidence behind them, and what is actually changing in daily functioning?
The 2018 study makes the last question the important one. Being on a medication is not the outcome. Something measurably changing is the outcome, and that requires someone to check.
Driving is one measurable example of a wider pattern. The guide to adult ADHD covers the other outcomes the research tracks, alongside what treatment does and does not change.
If you drive, and you have ADHD, this is worth raising directly with whoever manages your treatment. Not because you should be frightened out of your car, but because it is a specific, checkable question that rarely gets asked, and the answer may change what you and your prescriber decide is worth optimizing.
References
1. Chang Z, Quinn PD, Hur K, et al. Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes. JAMA Psychiatry. 2017;74(6):597 to 603. doi:10.1001/jamapsychiatry.2017.0659
2. Aduen PA, Kofler MJ, Sarver DE, Wells EL, Soto EF, Cox DJ. ADHD, depression, and motor vehicle crashes: a prospective cohort study of continuously-monitored, real-world driving. Journal of Psychiatric Research. 2018;101:42 to 49. doi:10.1016/j.jpsychires.2018.02.026
Clarity ADHD is a telehealth practice focused on adult ADHD care in Washington State offering adult ADHD evaluation and medication management, including care for co-occurring depression and anxiety. Now accepting new patients, and you can start with a free 15-minute consultation to see if it is a fit.
Book a Free 15-Minute ConsultationThe content on this website is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.